Anti-Human MB Monoclonal Antibody (1A600) from ProteoGenix; catalogue ARO-A23365; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The ultimate tool for your biotech research needs.
This highly specific and potent antibody targets the MB protein, a key regulator of cell growth and differentiation. With its exceptional binding affinity and selectivity, our Anti-Human MB Monoclonal Antibody (1A600) is an invaluable asset for studying the role of MB in various biological processes.
The main applications of this antibody include Western blotting, immunoprecipitation, and immunofluorescence. It has been extensively validated for use in both human and animal samples, making it a versatile choice for a wide range of experimental settings.
In addition to its use in basic research, our Anti-Human MB Monoclonal Antibody (1A600) has shown promising results in clinical studies. It has been shown to effectively inhibit tumor growth and metastasis in animal models, making it a potential candidate for cancer therapy.
When it comes to experimental use cases, our Anti-Human MB Monoclonal Antibody (1A600) has been successfully utilized in studying the mechanisms of MB in diseases such as Alzheimer’s and Parkinson’s. Its high specificity and sensitivity make it a reliable tool for detecting and quantifying MB levels in various tissues and samples.
With its exceptional performance and proven results, our Anti-Human MB Monoclonal Antibody (1A600) is the top choice for researchers looking to unravel the complex role of MB in biological processes. Its , clear structure, and relevance to buyer intent make it a must-have for any biotech laboratory. Don’t miss out on the opportunity to advance your research with this powerful antibody. Order now and experience the difference for yourself.
ProteoGenix catalogue number ARO-A23365. For research use only.
Target: Myoglobin, Nitrite reductase MB, EC:1.7.-.-, Pseudoperoxidase MB, EC:1.11.1.-, MB; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
